Bofa Merrill Lynch Health & Wellness Portfolio Series 1

Under normal circumstances, the Trust will invest at least 80% of the value of its assets in health and wellness companies. Health and wellness companies are companies that derive at least 50% of their profits or revenues from activities associated with health and wellness, or have 50% or more of their assets committed to these activities. The Trust seeks to provide a portfolio of approximately 30 companies which the Sponsor believes may stand to profit from the increased focus on health and wellness and desire to address the obesity epidemic. Obesity is increasingly becoming a persistent global problem involving millions of people and numerous countries. These health and wellness companies may be from industries that include, but are not limited to, areas such as pharmaceuticals, health care, commercial weight management and sports apparel/equipment. The Sponsor has referenced a list of securities published by Merrill Lynch Research and is solely responsible for the securities included in the Trust. Merrill Lynch Research has identified the stocks in the ordinary course of its research operations and without regard to the Trust or its unitholders.

The companies selected by the Sponsor for the Trust may include foreign companies. The Trust may invest such foreign securities directly or through U.S.-listed foreign securities, American Depositary Receipts (“ADRs”) or CHESS Depositary Interests (“CDIs”). ADRs are issued by a bank or Trust company to evidence ownership of underlying securities issued by foreign corporations. CDIs are units of beneficial ownership in foreign securities that are quoted on the Australian Securities Exchange and are held by an Australian depositary entity. In addition, the Trust may invest in companies of any market capitalization. As a result of the strategy, the Trust is concentrated in the health care and consumer products sectors.

Guggenheim Partners Investment Management, LLC

Guggenheim Partners Investment Management, LLC is a subsidiary of Guggenheim Partners, LLC and an affiliate of the Sponsor, which offers financial services expertise within its asset management, investment advisory, capital markets, institutional finance and merchant banking business lines. Clients consist of a mix of individuals, family offices, endowments, foundations, insurance companies, pension plans and other institutions that together have entrusted the firm with supervision of more than $100 billion in assets. A global diversified financial services firm, Guggenheim Partners, LLC office locations include New York, Chicago, Los Angeles, Miami, Boston, Philadelphia, St. Louis, Houston, London, Dublin, Geneva, Hong Kong, Singapore, Mumbai and Dubai.

The Sponsor is also a subsidiary of Guggenheim Partners, LLC. See “General Information” for additional information.

As with all investments, you may lose some or all of your investment in the Trust. No assurance can be given that the Trust’s investment objective will be achieved. The Trust also might not perform as well as you expect. This can happen for reasons such as these:

• Securities prices can be volatile. The value of your investment may fall over time. Market value fluctuates in response to various factors. These can include stock market movements, purchases or sales of securities by the Trust, government policies, litigation, and changes in interest rates, inflation, the financial condition of the securities’ issuer or even perceptions of the issuer. Units of the Trust are not deposits of any bank and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.

• The Trust is concentrated in the health care sector. As a result, the factors that impact the health care sector will likely have a greater effect on this Trust than on a more broadly diversified Trust. General risks of companies in the health care sector include extensive competition, generic drug sales, the loss of patent protection, product liability litigation and increased government regulation.

• The Trust is concentrated in the consumer products sector. As a result, the factors that impact the consumer products sector will likely have a greater effect on this Trust than on a more broadly diversified Trust. General risks of companies in the consumer products sector include cyclicality of revenues and earnings, economic recession, currency fluctuations, changing consumer tastes, extensive competition, product liability litigation and increased government regulation. A weak economy and its effect on consumer spending would adversely affect companies in the consumer products sector.

• The Trust invests in an ADR, a CDI and foreign securities listed on foreign exchanges. The Trust’s investment in an ADR, a CDI and foreign securities listed on foreign exchanges presents additional risk. ADRs are issued by a bank or Trust company to evidence ownership of underlying securities issued by foreign corporations. Securities of foreign issuers present risks beyond those of domestic securities. More specifically, foreign risk is the risk that foreign securities will be more volatile than U.S. securities due to such factors as adverse economic, currency, political, social or regulatory developments in a country, including government seizure of assets, excessive taxation, limitations on the use or transfer of assets, the lack of liquidity or regulatory controls with respect to certain industries or differing legal and/or accounting standards.

• The Trust includes securities whose value may be dependent on currency exchange rates. The U.S. dollar value of these securities may vary with fluctuations in foreign exchange rates. Most foreign currencies have fluctuated widely in value against the U.S. dollar for various economic and political reasons such as the activity level of large international commercial banks, various central banks, speculators, hedge funds and other buyers and sellers of foreign currencies.

• The Trust invests in securities issued by small-capitalization and mid-capitalization companies. These securities customarily involve more investment risk than securities of large-capitalization companies. Small-capitalization and mid-capitalization companies may have limited product lines, markets or financial resources and may be more vulnerable to adverse general market or economic developments.

• Share prices or dividend rates on the securities in the Trust may decline during the life of the Trust. There is no guarantee that share prices of the securities in the Trust will not decline and that the issuers of the securities will declare dividends in the future and, if declared, whether they will remain at current levels or increase over time.

• Inflation may lead to a decrease in the value of assets or income from investments.

• The Sponsor does not actively manage the portfolio. The Trust will generally hold, and may, when creating additional units, continue to buy, the same securities even though a security’s outlook, market value or yield may have changed.

See “Investment Risks” in Part A of the prospectus and “Risk Factors” in Part B of the prospectus for additional information.